|

Standard Medical treatment Clinical Trials

4 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Institute of Liver and Biliary Sciences, India1
  • European Foundation for Study of Chronic Liver Failure1
  • Beijing 302 Hospital1
  • Ain Shams University1

Indications

  • Liver Disease3
  • Acute on Chronic Liver Failure (ACLF)1
  • Decompensated Cirrhosis of Liver1
  • Acute Liver Failure1
  • Acute on Chronic Liver Failure1

Other4 trials

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Phase 2
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Phase 1/2
Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
N/A
the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.